The ovarian cancer is one of the most prevalent types of cancer in women. Due to the lack of methods to detect ovarian cancer in an early stage, survival rates of ovarian cancer patients are very low. The new research published suggests that targeted drug can subdue the spread of ovarian cancer to the other parts of the body. Ovarian cancer is one of the most common types of cancer in women. According to the data, over 1,50,000 women lose their life. The survival rate for ovarian cancer is only 40%, which is very low.
This is due to the fact that ovarian cancer is very hard to detect in the early stages. The lack of detection kits and obvious symptoms make the detection very challenging. As a result, the cancer is diagnosed in the later stages. The reasons behind ovarian cancer spread are not fully understood. The genes and molecules involved in the onset and spread of the ovarian…
